View in EDS

Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.

Saved in:
Bibliographic Details
Title: Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.
Authors: Stelljes M; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany., Raffel S; Department of Medicine, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Alakel N; Medizinische Klinik und Poliklinik I, Universitätsklinikum, Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Wäsch R; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Kondakci M; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Scholl S; Klinik für Innere Medizin II, Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany., Rank A; Department of Hematology and Oncology, University Medical Center Augsburg, Augsburg, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Spriewald B; Department of Internal Medicine V, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany., Hanoun M; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany., Martin S; Department of Hematology and Oncology, Robert-Bosch-Hospital, Stuttgart, Germany., Schwab K; Department of Medicine III, Hematology, Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Serve H; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany., Reiser L; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany., Knaden J; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany., Pfeifer H; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany., Marx J; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany., Sauer T; Department of Medicine, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Berdel WE; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany., Lenz G; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany., Brüggemann M; Department of Medicine II, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Gökbuget N; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany., Wethmar K; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jan 20; Vol. 42 (3), pp. 273-282. Date of Electronic Publication: 2023 Oct 26.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37883727
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stelljes+M%22">Stelljes M</searchLink>; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Raffel+S%22">Raffel S</searchLink>; Department of Medicine, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Alakel+N%22">Alakel N</searchLink>; Medizinische Klinik und Poliklinik I, Universitätsklinikum, Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Wäsch+R%22">Wäsch R</searchLink>; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kondakci+M%22">Kondakci M</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Scholl+S%22">Scholl S</searchLink>; Klinik für Innere Medizin II, Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Rank+A%22">Rank A</searchLink>; Department of Hematology and Oncology, University Medical Center Augsburg, Augsburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hänel+M%22">Hänel M</searchLink>; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.<br /><searchLink fieldCode="AU" term="%22Spriewald+B%22">Spriewald B</searchLink>; Department of Internal Medicine V, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Hanoun+M%22">Hanoun M</searchLink>; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Martin+S%22">Martin S</searchLink>; Department of Hematology and Oncology, Robert-Bosch-Hospital, Stuttgart, Germany.<br /><searchLink fieldCode="AU" term="%22Schwab+K%22">Schwab K</searchLink>; Department of Medicine III, Hematology, Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Serve+H%22">Serve H</searchLink>; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Reiser+L%22">Reiser L</searchLink>; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Knaden+J%22">Knaden J</searchLink>; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Pfeifer+H%22">Pfeifer H</searchLink>; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Marx+J%22">Marx J</searchLink>; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Sauer+T%22">Sauer T</searchLink>; Department of Medicine, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Berdel+WE%22">Berdel WE</searchLink>; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Lenz+G%22">Lenz G</searchLink>; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Brüggemann+M%22">Brüggemann M</searchLink>; Department of Medicine II, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Gökbuget+N%22">Gökbuget N</searchLink>; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Wethmar+K%22">Wethmar K</searchLink>; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2024 Jan 20; Vol. 42 (3), pp. 273-282. <i>Date of Electronic Publication: </i>2023 Oct 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37883727
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.23.00546
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 273
    Titles:
      – TitleFull: Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stelljes M
      – PersonEntity:
          Name:
            NameFull: Raffel S
      – PersonEntity:
          Name:
            NameFull: Alakel N
      – PersonEntity:
          Name:
            NameFull: Wäsch R
      – PersonEntity:
          Name:
            NameFull: Kondakci M
      – PersonEntity:
          Name:
            NameFull: Scholl S
      – PersonEntity:
          Name:
            NameFull: Rank A
      – PersonEntity:
          Name:
            NameFull: Hänel M
      – PersonEntity:
          Name:
            NameFull: Spriewald B
      – PersonEntity:
          Name:
            NameFull: Hanoun M
      – PersonEntity:
          Name:
            NameFull: Martin S
      – PersonEntity:
          Name:
            NameFull: Schwab K
      – PersonEntity:
          Name:
            NameFull: Serve H
      – PersonEntity:
          Name:
            NameFull: Reiser L
      – PersonEntity:
          Name:
            NameFull: Knaden J
      – PersonEntity:
          Name:
            NameFull: Pfeifer H
      – PersonEntity:
          Name:
            NameFull: Marx J
      – PersonEntity:
          Name:
            NameFull: Sauer T
      – PersonEntity:
          Name:
            NameFull: Berdel WE
      – PersonEntity:
          Name:
            NameFull: Lenz G
      – PersonEntity:
          Name:
            NameFull: Brüggemann M
      – PersonEntity:
          Name:
            NameFull: Gökbuget N
      – PersonEntity:
          Name:
            NameFull: Wethmar K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 01
              Text: 2024 Jan 20
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1